相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
Shelize Khakoo et al.
CLINICAL CANCER RESEARCH (2020)
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie et al.
GUT (2019)
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial
S. Hrebien et al.
ANNALS OF ONCOLOGY (2019)
Clinical utility of circulating tumor DNA for colorectal cancer
Hiroki Osumi et al.
CANCER SCIENCE (2019)
Life and death of circulating cell-free DNA
Anatoli Kustanovich et al.
CANCER BIOLOGY & THERAPY (2019)
Correlation between early dynamics in circulating tumour DNA and outcome from FOLFIRI treatment in metastatic colorectal cancer
Iben Lyskjaer et al.
SCIENTIFIC REPORTS (2019)
Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer
Hiroki Osumi et al.
SCIENTIFIC REPORTS (2019)
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Mifanwy Reece et al.
FRONTIERS IN GENETICS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Quantifying circulating cell-free DNA in humans
Romain Meddeb et al.
SCIENTIFIC REPORTS (2019)
Predicting treatment outcome of rectal cancer patients underwent neoadjuvant chemoradiotherapy by ctDNA: The potential use of ctDNA monitoring as organ-sparing approach.
Lifeng Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
Changhoon Song et al.
CANCERS (2018)
Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
Veronika Vymetalkova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature
Sonia Khier et al.
FUTURE SCIENCE OA (2018)
Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab
Rajiv Raja et al.
CLINICAL CANCER RESEARCH (2018)
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
Delphine Dayde et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine
Hatim Husain et al.
CLINICAL CANCER RESEARCH (2017)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2017)
Predictive value of circulating tumor DNA in locally advanced rectal cancer patients receiving neoadjuvant radiochemotherapy.
Min Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
Wenjie Sun et al.
ONCOTARGET (2016)
Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J. Tie et al.
ANNALS OF ONCOLOGY (2015)
Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer
David Sefrioui et al.
DIGESTIVE AND LIVER DISEASE (2015)
The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation
Paola Carpinetti et al.
ONCOTARGET (2015)
Pretreatment Expression of 13 Molecular Markers as a Predictor of Tumor Responses After Neoadjuvant Chemoradiation in Rectal Cancer
Jung Wook Huh et al.
ANNALS OF SURGERY (2014)
Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma
Karen-Lise Garm Spindler et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer
Pietro Contin et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Tumor Regression Grading After Preoperative Chemoradiotherapy for Locally Advanced Rectal Carcinoma Revisited: Updated Results of the CAO/ARO/AIO-94 Trial
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients
L. Benesova et al.
ANALYTICAL BIOCHEMISTRY (2013)
Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer
A. Elmi et al.
CLINICAL RADIOLOGY (2013)
73P GENE MUTATIONS IN SQUAMOUS-CELL NSCLC: INSIGNIFICANCE OF EGFR, KRAS AND PIK3CA MUTATIONS IN PREDICTION OF EGFR-TKI TREATMENT EFFICACY
O. Fiala et al.
LUNG CANCER (2013)
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy
Brunella Barbaro et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
VALUE OF DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING FOR PREDICTION AND EARLY ASSESSMENT OF RESPONSE TO NEOADJUVANT RADIOCHEMOTHERAPY IN RECTAL CANCER: PRELIMINARY RESULTS
Maarten Lambrecht et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer
Min-Bin Chen et al.
PLOS ONE (2012)
Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer
Julio Garcia-Aguilar et al.
ANNALS OF SURGERY (2011)
Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy
Marco Agostini et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer
Peter P. Grimminger et al.
CLINICAL CANCER RESEARCH (2011)
Somatic TP53 Mutation Mosaicism in a Patient With Li-Fraumeni Syndrome
Kamila Prochazkova et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: A potential diagnostic tool for therapy monitoring
Matthias Zitt et al.
DISEASE MARKERS (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
The Swedish rectal cancer registry
L. Pahlman et al.
BRITISH JOURNAL OF SURGERY (2007)
Dynamic T1 mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma:: Sequence implementation and data analysis
Christian Kremser et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
Frank Diehl et al.
NATURE METHODS (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Adverse effects of preoperative radiation therapy for rectal cancer:: Long-term follow-up of the Swedish rectal cancer trial
H Birgisson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
BRAF mutation detection and identification by cycling temperature capillary electrophoresis
DC Hinselwood et al.
ELECTROPHORESIS (2005)
Application of cycling gradient capillary electrophoresis to detection of K-ras and DCC point mutations in patients with sporadic colorectal tumors
M Minarik et al.
ELECTROPHORESIS (2004)
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma
AF DeVries et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Prognostic value of p53 mutations in rectal carcinoma
C Rebischung et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Treatment resistance of solid tumors - Role of hypoxia and anemia
P Vaupel et al.
MEDICAL ONCOLOGY (2001)
Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy
P Luna-Pérez et al.
ANNALS OF SURGICAL ONCOLOGY (2000)
分享论文
